BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21475010)

  • 1. Clinical significance of the mesorectal extension of rectal cancer: a Japanese multi-institutional study.
    Shirouzu K; Akagi Y; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K;
    Ann Surg; 2011 Apr; 253(4):704-10. PubMed ID: 21475010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting oncologic outcomes by stratifying mesorectal extension in patients with pT3 rectal cancer: a Japanese multi-institutional study.
    Akagi Y; Shirouzu K; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K;
    Int J Cancer; 2012 Sep; 131(5):1220-7. PubMed ID: 22025276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer.
    Shin R; Jeong SY; Yoo HY; Park KJ; Heo SC; Kang GH; Kim WH; Park JG
    Dis Colon Rectum; 2012 Dec; 55(12):1220-8. PubMed ID: 23135579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
    Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
    Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrence after mesorectal excision for rectal cancer.
    Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
    Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive versus open total mesorectal excision for rectal cancer: Long-term results from a case-matched study of 633 patients.
    Cho MS; Kim CW; Baek SJ; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    Surgery; 2015 Jun; 157(6):1121-9. PubMed ID: 25737005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
    Taylor FG; Quirke P; Heald RJ; Moran BJ; Blomqvist L; Swift IR; Sebag-Montefiore D; Tekkis P; Brown G;
    J Clin Oncol; 2014 Jan; 32(1):34-43. PubMed ID: 24276776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria.
    Merkel S; Weber K; Schellerer V; Göhl J; Fietkau R; Agaimy A; Hohenberger W; Hermanek P
    Br J Surg; 2014 Apr; 101(5):566-72. PubMed ID: 24477831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early rectal cancer: local excision or radical surgery?
    Chang AJ; Nahas CS; Araujo SE; Nahas SC; Marques CF; Kiss DR; Cecconello I
    J Surg Educ; 2008; 65(1):67-72. PubMed ID: 18308284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
    Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer.
    Leite JS; Martins SC; Oliveira J; Cunha MF; Castro-Sousa F
    Colorectal Dis; 2011 Apr; 13(4):381-6. PubMed ID: 20002696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
    Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
    Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic versus open techniques in rectal cancer surgery: a retrospective analysis of 121 sphincter-saving procedures in a single institution.
    Lam HD; Stefano M; Tran-Ba T; Tinton N; Cambier E; Navez B
    Surg Endosc; 2011 Feb; 25(2):454-62. PubMed ID: 20607562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer.
    Heide J; Krüll A; Berger J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):773-8. PubMed ID: 14967433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
    Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
    World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification.
    Dekker JW; Peeters KC; Putter H; Vahrmeijer AL; van de Velde CJ
    Eur J Surg Oncol; 2010 Dec; 36(12):1180-6. PubMed ID: 20884164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
    Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
    Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.